Search

Search Constraints

You searched for: Author/Creator Belli, C.

Search Results

1. 304 EPIDEMIOLOGICAL AND PROGNOSTIC FACTORS FROM THE ARGENTINEAN MDS REGISTRY. Issue 1 (April 2015)

2. 83P The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies "pure" IRAEs strongly associated with outcome in a phase I-II trial population. (December 2022)

3. Access to Diagnostic and Therapeutic Tools for Myelodysplastic Syndromes in General Practice: Survey Among South-American Hematologists. (April 2017)

5. Clinical and Prognostic Features in a Series of 277 Patients with Chronic Myelomonocytic Leukemia (CMML) from South America: A Multicenter Study. (April 2017)

6. Higher Risk Patients Under Hypomethylating Agents – A Multicentric Experience from Latin America. (April 2017)

7. Lower-Risk Patients that Required Hypomethylating Agents. A Multicentric Experience from Latin America. (April 2017)

8. P175 Characteristics and Survival Outcomes of Breast Cancer Patients Discussed at Molecular Tumor Board of European Institute of Oncology. (April 2023)

9. P536: VALUE OF MEASURABLE RESIDUAL DISEASE BY MULTIPARAMETRIC FLOW CYTOMETRY IN NON-PROMYELOCYTIC ACUTE MYELOID LEUKEMIA. REAL WORLD EVIDENCE. (23rd June 2022)

10. P764: RESPONSE AND SURVIVAL OUTCOMES WITH HYPOMETHYLATING AGENTS IN AN ARGENTINEAN COHORT OF 113 PATIENTS WITH CHRONIC MYELOMONOCITIC LEUKEMIA. (23rd June 2022)